M Kawaguchi

Summary

Affiliation: University of Tsukuba
Country: Japan

Publications

  1. ncbi IL-17F-induced IL-11 release in bronchial epithelial cells via MSK1-CREB pathway
    Mio Kawaguchi
    Department of Respiratory Medicine, University of Tsukuba, Ibaraki 3058575, Japan
    Am J Physiol Lung Cell Mol Physiol 296:L804-10. 2009
  2. ncbi Role of interleukin-17F in asthma
    Mio Kawaguchi
    Department of Respiratory Medicine, Institute of Clinical Medicine, University of Tsukuba, Ibaraki 3058575, Japan
    Inflamm Allergy Drug Targets 8:383-9. 2009
  3. ncbi Induction of insulin-like growth factor-I by interleukin-17F in bronchial epithelial cells
    M Kawaguchi
    Department of Respiratory Medicine, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan
    Clin Exp Allergy 40:1036-43. 2010
  4. ncbi Interleukin-33 induces interleukin-17F in bronchial epithelial cells
    J Fujita
    Department of Pulmonary Medicine, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan
    Allergy 67:744-50. 2012
  5. ncbi Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3
    T Kiwamoto
    Department of Respiratory Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
    Clin Exp Allergy 41:116-28. 2011

Collaborators

Detail Information

Publications5

  1. ncbi IL-17F-induced IL-11 release in bronchial epithelial cells via MSK1-CREB pathway
    Mio Kawaguchi
    Department of Respiratory Medicine, University of Tsukuba, Ibaraki 3058575, Japan
    Am J Physiol Lung Cell Mol Physiol 296:L804-10. 2009
    ..Therefore, the IL-17F/IL-11 axis may be a valuable therapeutic target for asthma...
  2. ncbi Role of interleukin-17F in asthma
    Mio Kawaguchi
    Department of Respiratory Medicine, Institute of Clinical Medicine, University of Tsukuba, Ibaraki 3058575, Japan
    Inflamm Allergy Drug Targets 8:383-9. 2009
    ..Hence, IL-17F may have a crucial role in allergic airway inflammation, and have important therapeutic implications in asthma...
  3. ncbi Induction of insulin-like growth factor-I by interleukin-17F in bronchial epithelial cells
    M Kawaguchi
    Department of Respiratory Medicine, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan
    Clin Exp Allergy 40:1036-43. 2010
    ..Insulin-like growth FACTOR-I (IGF-I) is known to be involved in airway remodelling and inflammation, while its regulatory mechanisms remain to be defined...
  4. ncbi Interleukin-33 induces interleukin-17F in bronchial epithelial cells
    J Fujita
    Department of Pulmonary Medicine, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan
    Allergy 67:744-50. 2012
    ..However, the regulatory mechanisms of IL-17F expression remain to be defined. To further indentify the role of IL-33 in asthma, we investigated the expression of IL-17F by IL-33 in bronchial epithelial cells and its signaling mechanisms...
  5. ncbi Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3
    T Kiwamoto
    Department of Respiratory Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
    Clin Exp Allergy 41:116-28. 2011
    ..We demonstrated previously that GATA-3 overexpression markedly enhanced allergen-induced airway inflammation and airway remodelling, including subepithelial fibrosis, and smooth muscle cell hyperplasia, in transgenic mice...